Former Medtronic (NYSE:MDT) CEO Bill George says the Covidien (NYSE:COV) deal is about more than inversion in this interview with Squawkbox on MSNBC.
Home » Former Medtronic CEO Bill George bullish on Medtronic/Covidien deal
More recent news
- Medtech M&A could be on the rise in 2025
- SetPoint Medical submits neuromod device to FDA
- AngioDynamics wins FDA clearance for NanoKnife system in prostate tissue ablation
- InspireMD begins pivotal study of CGuard Prime in TCAR procedures
- Anteris Technologies launches IPO to support heart valve technology
